Helga H Hektoen

8PUBLICATIONS
10CO-AUTHORS
Solid tumoursPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 08, 2026
Real-world outcomes of immunotherapy in advanced NSCLC patients with comorbidities.

|Apr 29, 2025
Let's talk about sex: Survival among females and males in a real-world cohort treated with pembrolizumab for non-small cell lung cancer.

Kaitlyn M Tsuruda, Helga H Hektoen, Christina Aamelfot

|Feb 10, 2023
Applying recommended definition of aggressive prostate cancer: a validation study using high-quality data from the Cancer Registry of Norway.

T E Robsahm, K M Tsuruda, H H Hektoen

|Sep 22, 2021
Prediagnostic Serum 25-Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort.

Helga H Hektoen, Randi E Gislefoss, Jo S Stenehjem

|Jun 03, 2021
Vitamin D and Vitamin D-binding protein and risk of bladder cancer: A nested case-control study in the Norwegian Janus Serum Bank Cohort.

Helga H Hektoen, Trude E Robsahm, Jo S Stenehjem

|Apr 23, 2020
Lifestyle associated factors and risk of urinary bladder cancer: A prospective cohort study from Norway.

Helga H Hektoen, Trude E Robsahm, Bettina K Andreassen

Pageof 2

Frequent Collaborators

5 joint publications

Trude E Robsahm

4 joint publications

Jo S Stenehjem

3 joint publications

Kaitlyn M Tsuruda

2 joint publications

Bettina Kulle Andreassen